Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Although the strategy of artesunate development was orchestrated from within WHO's Special Programme for Research and Training in Tropical Diseases, it relies heavily upon an alliance of scientist, laboratories, industry, regulators and ministries of health to ensure the public health outcome. This development strategy has transformed the way in which WHO does business, both within and outside the Organization. In essence, each and every player has rallied in the challenge to reduce the discrepancy between need and availability of a drug that can has the potential to reduce mortality form the disease.


Journal article


Medecine tropicale : revue du Corps de sante colonial

Publication Date





97 - 100


Special Programme for Research and Training in Tropical Diseases, TDR/WHO, Geneva, Switzerland.


Humans, Malaria, Sesquiterpenes, Artemisinins, Antimalarials, Drug Evaluation, Preclinical, Endemic Diseases, Public Health Practice, International Cooperation, Drug and Narcotic Control, Poverty, Drug Industry, Health Services Needs and Demand, World Health Organization, Africa, United States, Europe, Research Support as Topic